November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Peter Schmid’s findings on atezolizumab and sacituzumab govitecan for advanced TNBC – ESMO
Jun 29, 2024, 03:18

Peter Schmid’s findings on atezolizumab and sacituzumab govitecan for advanced TNBC – ESMO

ESMO shared a post on LinkedIn:

“For ESMO members: Breaking Science in Breast Cancer.
Peter Schmid presents his findings on atezolizumab and sacituzumab govitecan for advanced Triple-negative breast cancer (TNBC).
Explore this video and others from this series on OncologyPRO now.”

Additional information
Source: ESMO/LinkedIn